Applied Therapeutics | 10-Q:季度報表
Applied Therapeutics | 8-K:應用療法公佈2024年第三季度財務業績
Applied Therapeutics | SC 13G:超過5%持股股東披露文件-Morgan Stanley(8.6%),Morgan Stanley Capital Services LLC(7.0%)
Applied Therapeutics | SCHEDULE 13G/A:其他
Applied Therapeutics | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(6.0%)
Applied Therapeutics | 4:持股變動聲明-高管 Perfetti Riccardo
Applied Therapeutics | 4:持股變動聲明-高管 Funtleyder Leslie D.
Applied Therapeutics | 4:持股變動聲明-高管 Shendelman Shoshana
Applied Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Shoshana Shendelman(6.6%)
Applied Therapeutics | 144:擬議出售證券
Applied Therapeutics | 10-Q:2024財年二季報
Applied Therapeutics | 8-K:應用療法公佈2024年第二季度財務業績
Applied Therapeutics | 4:持股變動聲明-高管 Shendelman Shoshana
Applied Therapeutics | 4:持股變動聲明-高管 Perfetti Riccardo
Applied Therapeutics | 4:持股變動聲明-高管 Funtleyder Leslie D.
Applied Therapeutics | 4:持股變動聲明-董事 Kanter Stacy J.
Applied Therapeutics | 4:持股變動聲明-董事 SKYLER JAY S
Applied Therapeutics | 4:持股變動聲明-董事 MARCUS JOEL S
Applied Therapeutics | 4:持股變動聲明-董事 Lerner Teena
Applied Therapeutics | 4:持股變動聲明-股東 ALEXANDRIA REAL ESTATE EQUITIES, INC.
暫無數據
暫無數據